ViroGates A/S

ViroGates A/S EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of ViroGates A/S (VIRO.CO) as of Oct 18, 2026 is -22.20. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -8.90 — a change of 149.43% (lower).

EV/OCF

-22.20

YoY

149.43%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of ViroGates A/S is 2025 -22.20 . EV/OCF (Enterprise Value to Operating Cash Flow) of ViroGates A/S was 2024 -8.90 . It decreases by 149.43% lower compared to the previous year.

The ViroGates A/S EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
-3.25 DKK
Jan 1, 2019
-3.98 DKK
Jan 1, 2020
-5.11 DKK
Jan 1, 2021
-4.59 DKK
Jan 1, 2022
-7.24 DKK
Jan 1, 2023
-8.42 DKK
Jan 1, 2024
-8.90 DKK
Jan 1, 2025
-22.20 DKK
The ViroGates A/S EV/OCF history
YEAREV/OCFYoY
-22.20+149.43%
-8.90+5.73%
-8.42+16.26%
-7.24+57.76%
-4.59-10.18%
-5.11+28.54%
-3.98+22.46%
-3.25-81.93%
-17.96+13.75%
-15.79+6.76%
-14.79—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ViroGates A/S Stock analysis

What does ViroGates A/S do? ViroGates A/S, listed on the Copenhagen Stock Exchange with ticker VIRO.CO, operates in the Health Care sector. The company develops and markets diagnostic products, including the suPARnostic line, which measures soluble urokinase Plasminogen Activator Receptor (suPAR) in blood. suPAR levels indicate immune activation and are linked to infectious diseases such as HIV-1, malaria, tuberculosis, and sepsis. suPARnostic offers a Quantitative Point of Care Quick Triage test for acute care triage and a Quantitative ELISA Assay for clinical use. The company has 28 employees and was listed in 2018. ViroGates A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ViroGates A/S stock

EV/OCF (Enterprise Value to Operating Cash Flow) of ViroGates A/S is -22.20 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of ViroGates A/S changed from -8.90 to -22.20, representing a 149.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) ViroGates A/S since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s ViroGates A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — ViroGates A/S

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — ViroGates A/S